D
Till Capital Corporation TIL.V
TSX
Recommendation
Sell
Prev Close
$3.89
Volume
--
Avg Vol (90D)
40
Market Cap
$9.20M
Dividend & Yield
--
52-Week Range
$2.51 - $6.19
P/E (TTM)
--
EPS (TTM)
-$0.7638
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Positive Financial Outlook for Instil Bio: A Comprehensive Analysis of the CoStAR TIL Platform and Valuation Risks
11/14/2023 - TipRanks Financial Blog
Instil Bio Non-GAAP EPS of -$0.16 misses by $0.01
11/14/2023 - SeekingAlpha.com: All News
Instil Bio reports Q3 EPS (16c), consensus (10c)
11/13/2023 - The Fly
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
11/13/2023 - Globe Newswire
Instil Bio announces presentations on ITIL-306 data at SITC Meeting
11/6/2023 - The Fly
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting
11/6/2023 - Globe Newswire
After Plunging -18.52% in 4 Weeks, Here's Why the Trend Might Reverse for Instil Bio, Inc. (TIL)
8/31/2023 - Zacks Investment Research
After Plunging -18.52% in 4 Weeks, Here's Why the Trend Might Reverse for Instil Bio, Inc. (TIL)
8/31/2023 - Zacks Investment Research
Analysts Are Bullish on Top Healthcare Stocks: Relay Therapeutics (RLAY), Instil Bio (TIL)
8/17/2023 - TipRanks Financial Blog
Instil Bio GAAP EPS of -$0.14
8/14/2023 - SeekingAlpha.com: All News
Instil Bio reports Q2 EPS (11c), consensus (16c)
8/14/2023 - The Fly
Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8/14/2023 - Globe Newswire
Instil Bio (TIL) Gets a Buy from H.C. Wainwright
6/29/2023 - TipRanks Financial Blog
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
6/26/2023 - Globe Newswire
Analysts Offer Insights on Healthcare Companies: Instil Bio (TIL) and Regulus (RGLS)
5/15/2023 - TipRanks Financial Blog
Instil Bio GAAP EPS of -$0.44
5/11/2023 - SeekingAlpha.com: All News
Instil Bio Reports First Quarter 2023 Financial Results andProvides Corporate Update
5/11/2023 - Globe Newswire
Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
3/31/2023 - Globe Newswire
Instil Bio Announces Extension of Cash Runway Beyond 2026 with the Consolidation of R&D Operations to its Manchester, U.K. Site
1/31/2023 - Globe Newswire
Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-306 in Lung, Ovarian, and Renal Cancer
1/9/2023 - Globe Newswire
INSTIL BIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Instil Bio, Inc. on Behalf of Instil Bio Stockholders and Encourages Investors to Contact the Firm
12/30/2022 - Globe Newswire
Video: Thursday Sector Leaders: Biotechnology, Drugs
12/29/2022 - Market News Video
Video: Wednesday Sector Leaders: Biotechnology, Manufacturing Stocks
12/28/2022 - Market News Video
Down 61.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Instil Bio, Inc. (TIL)
12/13/2022 - Zacks Investment Research
Bragar Eagel & Squire, P.C. Is Investigating PROG, Fox, Instil, and Twist and Encourages Investors to Contact the Firm
12/13/2022 - Globe Newswire
Income Statement
Total Revenue (TTM)
$777.40K
EBITDA (TTM)
-$728.20K
EBIT (TTM)
-$731.60K
Net Income (TTM)
-$2.44M
Balance Sheet
Total Assets (Q)
$46.63M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$28.09M
Book Value Per Share (Q)
$5.48
Cash Flow
Cash from Operations (TTM)
$686.90K
Cash from Investing (TTM)
$1.10M
Cash from Financing (TTM)
-$251.10K
Net Change in Cash (TTM)
$1.55M
Filings
Filing Date
Thursday, November 16, 2023
Period Date
Saturday, September 30, 2023
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
-0.90
7-Day Total Return
8.06%
30-Day Total Return
-23.87%
60-Day Total Return
19.69%
90-Day Total Return
23.49%
Year to Date Total Return
-27.96%
1-Year Total Return
-27.83%
2-Year Total Return
-44.59%
3-Year Total Return
-2.75%
5-Year Total Return
75.23%
52-week Low
Sep 25, 2023 - $2.51
52-week High
Dec 20, 2022 - $6.19
Valuation
Market Cap
$9.20M - Nano Cap
Enterprise Value
$8.10M
Price/Sales (TTM)
15.98
Price/Book (Q)
0.71
Dividends and Shares
Shares Outstanding
3.19M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.tillcap.com
Phone Number
208 635 5415
Address
Park Place
Suite 1700 - 666 Burrard Street
Vancouver, BC V6C 2X8
Country
Canada
Year Founded
2012
Business Description
Sector
Materials
Industry
Materials
Till Capital Corporation, together with its subsidiaries, engages in the mineral exploration activities. The company explores for silver, gold, copper, and other deposits. It owns various mineral... more
Weiss Ratings